|
2 Companies |
|
1 Product |
|
1 Product |
|
4 Mechanisms of Action |
|
0 Trials |
|
13 News |
|
- | Trial completion: UROHTLV: Urological Physical Therapy in HTLV-1 With Urinary Symptoms (clinicaltrials.gov) - Oct 5, 2018
P=N/A, N=20, Completed, Sponsor: Hospital Universitário Professor Edgard Santos
Enrolling by invitation --> Completed
- | Trial completion: Physiologic Studies of Spasticity (clinicaltrials.gov) - Jun 30, 2017
P=N/A, N=48, Completed, Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Enrolling by invitation --> Completed Recruiting --> Completed
- | Trial completion: Assessment of Patients With Multiple Sclerosis (MS) (clinicaltrials.gov) - Jun 30, 2017
P=N/A, N=1388, Completed, Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting --> Completed Recruiting --> Completed
- Trial primary completion date: UROHTLV: Urological Physical Therapy in HTLV-1 With Urinary Symptoms (clinicaltrials.gov) - Feb 21, 2016
P=N/A, N=20, Enrolling by invitation, Sponsor: Hospital Universitário Professor Edgard Santos
Recruiting --> Completed Trial primary completion date: Dec 2013 --> Dec 2014
- | Trial completion: Use Of Valproid Acid To Treat Tropical Spastic Paraparesis/HTLV-1-Associated Myelopathy (TSP/HAM) (clinicaltrials.gov) - Dec 5, 2015
P3, N=60, Completed, Sponsor: University of Sao Paulo
Trial primary completion date: Dec 2013 --> Dec 2014 Active, not recruiting --> Completed
- Biomarker, Trial completion: BIO_ALS-01: Validation of Biomarkers in Amyotrophic Lateral Sclerosis (ALS) (clinicaltrials.gov) - Nov 25, 2015
P=N/A, N=475, Completed, Sponsor: Massachusetts General Hospital
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Biomarker, Trial primary completion date: BIO_ALS-01: Validation of Biomarkers in Amyotrophic Lateral Sclerosis (ALS) (clinicaltrials.gov) - Apr 19, 2015
P=N/A, N=475, Active, not recruiting, Sponsor: Massachusetts General Hospital
Active, not recruiting --> Completed Trial primary completion date: Dec 2014 --> Dec 2015
- pentoxifylline / Generic mfg.
Trial completion: Use of Pentoxifylline in Human T-lymphotropic Virus Type-1 (HTLV-1) Diseases (clinicaltrials.gov) - Mar 18, 2015
P3, N=48, Completed, Sponsor: Hospital Universit
Trial primary completion date: Dec 2014 --> Dec 2015 Active, not recruiting --> Completed
- Trial primary completion date: UROHTLV: Urological Physical Therapy in HTLV-1 With Urinary Symptoms (clinicaltrials.gov) - Mar 12, 2015
P=N/A, N=20, Enrolling by invitation, Sponsor: Hospital Universitário Professor Edgard Santos
Active, not recruiting --> Completed Trial primary completion date: Jul 2014 --> Dec 2013
- Biomarker, Enrollment change: BIO_ALS-01: Validation of Biomarkers in Amyotrophic Lateral Sclerosis (ALS) (clinicaltrials.gov) - Mar 23, 2014
P=N/A, N=475, Active, not recruiting, Sponsor: Massachusetts General Hospital
Trial primary completion date: Jul 2014 --> Dec 2013 N=650 --> 475
- Clinical: UROHTLV: Urological Physical Therapy in HTLV-1 With Urinary Symptoms (clinicaltrials.gov) - Jul 25, 2012
P=N/A, N=20, Enrolling by invitation, Sponsor: Hospital Universitário Professor Edgard Santos
- Biomarker, Enrollment closed: BIO_ALS-01: Validation of Biomarkers in Amyotrophic Lateral Sclerosis (ALS) (clinicaltrials.gov) - Dec 11, 2011
P=N/A, N=475, Active, not recruiting, Sponsor: Massachusetts General Hospital
N=650 --> 475 Recruiting --> Active, not recruiting
- pentoxifylline / Generic mfg.
New P3 trial: Use of Pentoxifylline in Human T-lymphotropic Virus Type-1 (HTLV-1) Diseases (clinicaltrials.gov) - Nov 10, 2011
P3, N=48, Active, not recruiting, Sponsor: Hospital Universit